$CSCO — AVOID 📊 | 6 MONTHS THESIS

$CSCO — AVOID 📊 | 6 MONTHS THESIS 🎯 FQ3 FY2026 (ends Apr) | reported May 13 | Rev $15.8B | EPS $1.06 vs $1.04 🟢 | Margin 25.0% 💡 The market expects steady low-single-digit growth and has priced in the beat, but consensus may underestimate the cyclical slowdown in IT networking. Even if Cisco meets its guidance, the multiple is stretched relative to history and peers, increasing downside risk on any miss. 🏢 Business Quality: 7/10 📊 Valuation: rich — forward non-GAAP P/E of ~28x vs. 5-year average of ~15–20x; EV/EBITDA of ~14x; expensive relative to networking peers like HPE (10x) and... 🔮 Catalyst: Q4 FY26 earnings release ⚖️ Avoid CSCO: rich valuation at 28x non-GAAP earnings limits upside despite solid execution, low quant ranks signal underperformance risk.

🎯 FQ3 FY2026 (ends Apr) | reported May 13 | Rev $15.8B | EPS $1.06 vs $1.04 🟢 | Margin 25.0%